-
Zelluna ASA: Third Quarter 2026 results
-
Zelluna ASA awarded NOK 15.6 million Research Council of Norway grant to further advance TCR-NK manufacturing
-
Zelluna ASA: Invitation to Third Quarter 2026 Results Webcast Including ZIMA-101 Clinical Progress Update
-
Zelluna ASA – Extraordinary General Meeting held on September 9, 2026
-
Zelluna ASA – Disclosure of voting rights of Extraordinary General Meeting
-
Zelluna ASA: Second Quarter 2026 results
-
Zelluna receives Independent Data Monitoring Committee recommendation to continue patient enrolment in ZIMA-101
-
Zelluna ASA: Notice of EGM – experienced international biotech executive proposed for election to the Board and Board member steps down
-
Zelluna ASA: Invitation to Second Quarter 2026 Results Webcast Presentation
-
Zelluna ASA: New share capital registered
